SCHEMBL4607086

SCHEMBL4607086

[CH2]C(CC)C[CH]C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1586803 0.77
SCHEMBL1586806 0.77
SCHEMBL2119484 0.75
SCHEMBL8594718 0.73
SCHEMBL27261289 0.73
SCHEMBL8119787 0.73
SCHEMBL7736563 0.73
SCHEMBL27785075 0.73
SCHEMBL9953523 0.73
SCHEMBL7749 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753619-B1 METHOD FOR PRODUCING FLEXOGRAPHIC PRINTING PLATES USING DIRECT LASER ENGRAVING FLINT GROUP GERMANY GMBH (DE) 2008-07-23 EP disclosed
EP-1753619-A1 METHOD FOR PRODUCING FLEXOGRAPHIC PRINTING PLATES USING DIRECT LASER ENGRAVING XSYS Print Solutions Deutschland GmbH (DE) 2007-02-21 EP disclosed
WO-2005113240-A1 METHOD FOR PRODUCING FLEXOGRAPHIC PRINTING PLATES USING DIRECT LASER ENGRAVING XSYS PRINT SOLUTIONS DEUTSCHLAND GMBH (DE) 2005-12-01 WO disclosed
CN-1036832-C Composition containing a penem or carbapenem artibiotic and the use of the same SANKYO CO (JP) 1997-12-31 CN disclosed
US-5658942-A Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition SANKYO COMPANY, LIMITED (JP) 1997-08-19 US disclosed
US-5604256-A (7-(5-(1,3-DIOXANE-5YL)METHOXYIMINO-2-METHYL-8-(2-METHYLBUTYR -OXY)3-OXO-1,2,3,5,6,7,8,8A-OCTAHYDRO-1-NAPHTHYL)-3-HYDROXY-5 -OXOHEPTANOIC ACID AND SALTS SANKYO COMPANY, LIMITED (JP) 1997-02-18 US disclosed
EP-0570245-B1 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use SANKYO CO (JP) 1996-10-30 EP disclosed
US-5403860-A Octahydronaphthalene oxime compounds for cholesterol synthesis inhibition SANKYO COMPANY, LIMITED (JP) 1995-04-04 US disclosed
EP-0570245-A2 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use SANKYO COMPANY LIMITED (JP) 1993-11-18 EP disclosed
EP-0314435-B1 OCTAHYDRONAPHTHALENE OXIME DERIVATIVES FOR CHOLESTEROL SYNTHESIS INHIBITION, PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM Sankyo Company Limited (JP) 1993-09-29 EP disclosed
EP-0226304-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1991-08-28 EP disclosed
US-4997848-A Enzyme inhibitors SANKYO COMPANY, LIMITED (JP) 1991-03-05 US disclosed
EP-0314435-A2 Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them Sankyo Company Limited (JP) 1989-05-03 EP disclosed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US disclosed
EP-0226304-A1 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1987-06-24 EP disclosed
CN-86107574-A Compositions containing penem or carbapenem antibiotics and their use 1987-05-20 CN disclosed
US-3971825-A (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS SANKYO COMPANY LIMITED (JA) 1976-07-27 US disclosed